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ABSTRACT Although the pathogen recognition receptor pathways that activate
cell-intrinsic antiviral responses are well delineated, less is known about how the
host regulates this response to prevent sustained signaling and possible immune-
mediated damage. Using a genome-wide CRISPR-Cas9 screening approach to iden-
tify host factors that modulate interferon-stimulated gene (ISG) expression, we
identified the DNA binding protein Barrier-to-autointegration factor 1 (Banf1), a
previously described inhibitor of retrovirus integration, as a modulator of basal
cell-intrinsic immunity. Ablation of Banf1 by gene editing resulted in chromatin
activation near host defense genes with associated increased expression of ISGs,
including Oas2, Rsad2 (viperin), Ifit1, and ISG15. The phenotype in Banf1-deficient
cells occurred through a cGAS-, STING-, and IRF3-dependent signaling axis, was
associated with reduced infection of RNA and DNA viruses, and was reversed in
Banf1 complemented cells. Confocal microscopy and biochemical studies re-
vealed that a loss of Banf1 expression resulted in higher level of cytosolic
double-stranded DNA at baseline. Our study identifies an undescribed role for
Banf1 in regulating the levels of cytoplasmic DNA and cGAS-dependent ISG ho-
meostasis and suggests possible therapeutic directions for promoting or inhibit-
ing cell-intrinsic innate immune responses.
IMPORTANCE Although the interferon (IFN) signaling pathway is a key host mecha-
nism to restrict infection of a diverse range of viral pathogens, its unrestrained activ-
ity either at baseline or in the context of an immune response can result in host cell
damage and injury. Here, we used a genome-wide CRISPR-Cas9 screen and identified
the DNA binding protein Barrier-to-autointegration factor 1 (Banf1) as a modulator
of basal cell-intrinsic immunity. A loss of Banf1 expression resulted in higher level of
cytosolic double-stranded DNA at baseline, which triggered IFN-stimulated gene ex-
pression via a cGAS-STING-IRF3 axis that did not require type I IFN or STAT1 signal-
ing. Our experiments define a regulatory network in which Banf1 limits basal inflam-
mation by preventing self DNA accumulation in the cytosol.
KEYWORDS interferon-stimulated gene, regulation, innate immunity, CRISPR, DNA
virus, RNA virus, antiviral, interferon
Mammalian cells detect and respond to RNA virus infection by recognizing non-selfRNA elements through multiple pathogen recognition receptors (PRRs), including
the cell surface and endosomal RNA sensors Toll-like receptors 3 and 7 (TLR3 and TLR7),
and the cytoplasmic RNA sensors retinoic acid-inducible gene I (RIG-I) and melanoma-
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differentiation-associated gene 5 (MDA5). Binding of single- and/or double-stranded
viral RNA to PRRs results in downstream activation of transcription factors, including
interferon (IFN) regulatory factors 3 and 7 (IRF-3 and IRF-7) and NF-B, and induction of
IFN- and -. Secretion of IFNs, followed by engagement of the IFN-/ receptor
(IFNAR), in an autocrine and paracrine fashion activates JAK/STAT-dependent signal
transduction cascades (1) that induce the expression of hundreds of ISGs, many of
which have antiviral activity (2). In addition to using RNA sensors, cells use DNA-sensing
machinery to detect DNA viruses or intracellular damage generated early during
infection by RNA or DNA viruses (3). As an example, leaked DNA from the mitochondria
or nucleus is detected by the DNA sensor cyclic GMP-AMP synthase (cGAS), which
triggers the stimulator of IFN genes (STING) and induction of type I IFN and ISGs. At
each stage of the immune response, stimulatory and inhibitory signals regulate the
magnitude, quality, and character of the response. Positive regulators amplify immune
response to clear viral infection, whereas negative regulators dampen inflammatory
responses to prevent immune-mediated tissue damage and spontaneous autoimmu-
nity (4).
Several ISGs can temper PRR and type I IFN responses (reviewed in references 4 and
5). As examples, the IFN-induced ring finger protein 125 (RNF125) can target RIG-I,
MDA5, and MAVS for ubiquitin-mediated proteasomal degradation (6). Members of the
tripartite motif (TRIM) family of E3 ubiquitin ligases inhibit IFN production by targeting
of key signaling molecules (e.g., TRIF, TBK1, and IKK) or transcription factors (IRF3, IRF7,
and NF-B) for ubiquitin-mediated degradation (7). The suppressor of cytokine signal-
ing (SOCS) family of proteins negatively regulates inflammation by targeting the
tyrosine kinase activity of Janus kinases (JAK), which inhibits JAK/STAT signaling
pathways and attenuates antiviral responses (8).
We set out to identify novel negative regulators of ISG induction in hopes of
identifying targets for inhibition that might allow enhanced viral clearance during acute
infections. We performed a genome-wide CRISPR-Cas9 screen in BV2 microglial cells
and evaluated for genes that, when edited, resulted in increased cell surface expression
of Bst2 (tetherin), a well-described ISG with antiviral activity against multiple enveloped
RNA and retroviruses (9, 10). One of our top “hits” was Barrier-to-autointegration factor
1 (Banf1), a small (10 kDa) conserved DNA-binding protein with homeostatic functions
in mitosis, nuclear assembly, and the DNA damage response (11, 12) that also can
recognize foreign DNA and prevent chromosomal integration (13) or genome replica-
tion (14). Banf1 is expressed normally in the inner nuclear membrane but can relocalize
to the cytoplasm depending on the stage of cell cycle and age of the cell (15). In
addition, Banf1 can bind to exogenous double-stranded DNA in the cytosol after
endosomal breakdown to avoid autophagy (16).
In our study, editing of Banf1 in BV2 mouse microglial cells (ΔBanf1) resulted in
increased surface expression of Bst2 and higher mRNA levels of several antiviral ISGs,
including Rsad2 and Oas2, and this occurred even when type I IFN signaling was
blocked. Reciprocally, ΔBanf1 cells complemented with wild-type Banf1 demonstrated
lower levels of ISGs than control, nonedited cells. These results with control, ΔBanf1,
and ΔBanf1Banf1 cells were confirmed by RNA sequencing (RNA-Seq) analysis, and
parallel chromatin immunoprecipitation sequencing (ChIP-Seq) studies revealed that
ΔBanf1 cells had active chromatin surrounding several host defense genes. Loss of
Banf1 expression was associated with reduced infection of RNA and DNA viruses, and
the enhanced expression of ISGs was mediated by a pathway requiring cGAS, STING,
and IRF3. Decreased expression of Banf1 also was associated with increased levels of
cytosolic double-stranded DNA, which likely triggered recognition by cGAS. Collec-
tively, these results suggest that Banf1, in addition to its established ability to inhibit
retrovirus integration and DNA virus replication, regulates levels of endogenous cyto-
plasmic double-stranded DNA at baseline, which prevents adventitious cGAS-STING
activation and cellular ISG responses.
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A genome-wide CRISPR/Cas9 screen identifies Banf1 as a negative regulator of
ISG expression. To screen for negative regulators of the IFN pathway, we established
a flow cytometry-based strategy with BV2 microglia cells using Bst2 (tetherin), a cell
surface protein induced by type I IFNs (Fig. 1A) (9), as an indicator of altered ISG
expression (Fig. 1B). Since Usp18 is an established negative regulator of the IFN
pathway (17), we generated ΔUsp18 BV2 cells (see Fig. S1A in the supplemental
material) as a positive control to validate the screening approach. When treated with
intermediate (10 to 100 IU/ml) doses of IFN-, ΔUsp18 BV2 cells differentially showed
higher levels of Bst2 on the cell surface than did control cells (Fig. S1B). Based on these
data, we used BV2-Cas9 cells with two independent CRISPR libraries, each with greater
than 20,000 small guide RNAs (sgRNA) targeting all of the protein-coding genes in the
mouse genome (18). The top 1% of cells expressing of the highest levels of Bst2 were
sorted by flow cytometry. After expansion in culture, a second round of sorting was
performed, and the cells expressing the highest surface levels of Bst2 again were
collected. Subsequently, genomic DNA was recovered, deep sequencing of the guide
RNAs was performed, and gene enrichment was determined using MAGeCK analysis
(19) (Table S1). We manually picked genes (e.g., Banf1, Cmas, Dhps, Gale, and Mgat2;
Fig. S2A) that ranked in the top 150 of both libraries for validation using two indepen-
dent sgRNA (Fig. S2B). Only one gene, Banf1, showed the desired phenotype of
FIG 1 A genome-wide CRISPR screen identified Banf1 as a negative regulator of ISG expression. (A) Bst2, an ISG expressed on
the cell surface, was used as a marker for a FACS-based screen for regulators of type I IFN signaling. Cell surface levels of Bst2
were determined after 16 h of IFN- stimulation in WT or Usp18/ cells. Usp18 is an established negative regulator of type
I IFN signaling (17). (B) Flow chart of a FACS-based screen to identify negative regulators of ISG expression. BV2 mouse
microglial cells that were transduced with a CRISPR-Cas9 library were treated with a threshold dose of IFN- and then sorted
(top 1%) for high level of Bst2 expression. After expansion, this procedure was repeated once, and then sgRNA sequences were
recovered after next-generation sequencing. (C and D) Banf1 was identified as a negative regulator of ISG expression. (C) An
immunoblot shows the Banf1 protein levels in different clonal cells (WT and Banf1 mutant BV2 cells [ΔBanf1] complemented
with Banf1 [TC] or empty vector). The data are representative of three experiments. (D) mRNA levels of Rsad2 and Oas2, two
representative ISGs, in ΔBanf1 cells. This phenotype is reversed by the ectopic expression of Banf1. The data are normalized
to WT control complemented with a control vector and expressed as means  standard deviations (SD). Three experiments
were each performed in triplicate, and the results were assessed using one-way ANOVA with Dunnett’s posttest (****, P 
0.0001).
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elevated levels of ISGs (Rsad2 [viperin] and Ifit1) in the two gene-edited cells compared
to control sgRNA cells (Fig. S2C). To rule out possible off-target effects, five additional
sgRNA against Banf1 were tested in bulk cell lines (Fig. S2D); these cells showed that a
deficiency of Banf1 expression resulted in enhanced ISG levels at baseline, even in the
absence of exogenous IFN- treatment. To confirm our findings, we generated a clonal
ΔBanf1 BV2 cell line (Fig. 1C and Fig. S2E), which showed elevated levels of ISGs (Rsad2
and Oas2), and performed complementation (Banf1 Banf1), which rescued the
phenotype (Fig. 1D). Of note, Banf1 cell line was not a complete null, since small
amounts of Banf1 were detected in immunoblots (Fig. 1C); this expression pattern was
anticipated as a complete loss of Banf1 is lethal during embryogenesis in invertebrates
(20). Notwithstanding this point, the cell viability and metabolic activity of uninfected
Banf1 hypomorphic cells were equivalent to the control or complemented cells
(Fig. S2F to G).
A deficiency in Banf1 results in global ISG expression. Our results suggested a
role for Banf1 in regulating basal ISG expression. To evaluate this in greater detail, we
paired global transcriptome and epigenetic profiling assays in BV2 cells deficient in
Banf1 (Banf1), complemented with Banf1 (TC), or control lines (WT). We first con-
ducted RNA-Seq analysis to identify differentially expressed genes. In Banf1 BV2 cells,
highly upregulated genes (cutoff  3 higher expression than WT cells and 	3 reads
per kb per million [RPKM]) were mostly ISGs (26 of 28 [21]) (Fig. 2A). Indeed, the gene
ontology response pathway to type I IFN (GO 0034340) was highly enriched in Banf1
BV2 cells (enrichment false discovery rate of 2.79E–11 [22]). We next determined the
activation status of genes using histone 3 lysine 27 acetylation (H3K27ac) chromatin
immunoprecipitation-sequencing (ChIP-Seq), since this mark correlates with active
enhancers and transcription. As an example, the Rsad2 promoter and a nearby putative
enhancer were active in the Banf1 cells but inactive in WT and TC cells, whereas the
-actin gene loci showed no difference in H3K27 acetylation status in any of the three
cells (Fig. 2B). To extend these observations, we compared H3K27 acetylation status on
a genome-wide level in TC and Banf1 cells (Fig. 2C and Fig. S3). Most of the regulatory
elements with differential H3K27 acetylation were proximal to known ISGs. Indeed, an
unbiased analysis using linked differential gene expression with chromatin activation,
revealed that the majority of direct targets in the Banf1 BV2 cells were established
ISGs (gene enrichment overlap with interferon alpha response P  5e–17 [hypergeno-
metric test]).
A deficiency in Banf1 is associated with reduced viral infection. Given the higher
basal level of ISGs in Banf1 cells, we hypothesized they might contribute to resistance
to virus infections. To evaluate this idea, we assessed infection of positive-sense RNA
viruses including a flavivirus (West Nile virus [WNV]-Kunjin virus) and an alphavirus
(chimeric Eastern equine encephalitis virus (SINV-EEEV), a negative-sense RNA virus
(vesicular stomatitis virus [VSV]), and a DNA virus (herpes simplex virus 1 [HSV-1]) in
Banf1 BV2 cells; these viruses were selected because they replicated efficiently in
parental BV2 cells. Multistep growth curve analysis showed that a deficiency of Banf1
was associated with less infection by HSV-1 and WNV-Kunjin compared to control cells
(Fig. 2D). To evaluate further the effect of Banf1 expression on the basal or rapidly
induced ISG response, we analyzed viral replication under inoculation conditions with
high and low multiplicities of infection with SINV-EEEV and VSV. These experiments
showed that Banf1 BV2 cells were more resistant than control cells (Fig. 2E and
Fig. S4). Reciprocally, Banf1 Banf1 complemented BV2 cells, which had lower levels
of ISG mRNA at baseline (Fig. 2A and C), showed greater infection with WNV-Kunjin and
SINV-EEEV (Fig. 2D and E and Fig. S4).
Basal ISG expression in Banf1 cells is independent of type I IFN signaling. Our
initial experiments showed that the induction of ISGs associated with decreased Banf1
expression did not require exogenous IFN- administration (Fig. S2C-D). We also found
no upregulation of IFN- mRNA in Banf1 cells (Fig. 3A). Since ISG induction can
happen in a type I IFN-independent manner (e.g., via IRF3 activation [23]), we first
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assessed whether the IFN signaling pathway was required for the ISG phenotype in
Banf1 cells. Administration of an inhibitor of Jak activity did not fully rescue the ISG
upregulation phenotype (Fig. 3B). We next edited Banf1 expression in wild-type (WT)
and Ifnar1/ murine embryonic fibroblasts (MEFs). As expected, Banf1 WT MEFs had
higher levels of ISGs (e.g., Rsad2 and Ifit1) than control gene-edited WT MEFs. Remark-
ably, Banf1 Ifnar1/ MEFs had a similar phenotype as Banf1 WT MEFs (Fig. 3C to E).
We confirmed these findings in Stat1 gene-edited BV2 cells (Fig. 3F and Fig. S5A and
B). Thus, in BV2 cells and fibroblasts, the ISG induction associated with loss of Banf1
expression occurred independently of type I IFN signaling.
ISG expression in Banf1 cells occurs via a cGAS/STING/IRF3 pathway. Prior
studies have suggested that Banf1 might regulate DNA damage responses (11). We
hypothesized that a loss of Banf1 expression might trigger sensing of self-DNA and
innate immune signaling. To evaluate this hypothesis, we first tested whether a
pharmacological inhibitor of STING (NO2-FA [24]) could rescue the ISG phenotype in
Banf1 BV2 cells. At concentrations that do not cause cellular cytotoxicity (Fig. S6A),
FIG 2 A deficiency of Banf1 results in global ISG upregulation and antiviral effects. (A to D) RNA-Seq and ChIP-seq analyses in control (WT), Banf1, and
Banf1Banf1 complemented (TC) BV2 cells. (A) Upregulated genes identified with RNA-Seq in ΔBanf1 cells compared to WT and to TC BV2 cells, with an at
least 3 higher expression and a minimum of three RPKM (reads per kb per million). The majority of these genes (26 of 28) are ISGs (http://www.interferome
.org/interferome/home.jspx). (B) UCSC Genome Browser snapshots showing gene location and H3K27 acetylation values (RPKM) for Rsad2 (top) and Actb
(bottom) loci in control (WT), ΔBanf1Banf1 complemented (TC), or ΔBanf1 BV2 cells. The Rsad2 promoter and a nearby putative enhancer are highlighted by
rectangular frames. (C) MA (Bland-Altman) plot showing the H3K27 acetylation values from ΔBanf1 or TC cells. Gray dots indicate H3K27 acetylation peaks whose
values differ at least 2-fold between groups and are above an average of 4 RPKM. Red labels indicate selected genes proximal (within 10 kb) of indicated
H3K27ac peaks. (D) Multistep growth curve of HSV-1 (MOI of 0.05) and WNV-Kunjin virus (MOI of 0.01) in WT, ΔBanf1, and TC BV2 cells. The virus titer is expressed
as PFU (for HSV-1) or as focus-forming units (FFU; for WNV-Kunjin) per ml. The data are from three experiments with duplicates (for HSV-1) or triplicates (for
WNV-Kunjin). Two-way ANOVA with Tukey’s posttest was performed (*, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001). Red asterisks, comparison of
ΔBanf1 to WT cells; blue asterisks, comparison of TC to WT cells. Dotted lines indicate limits of detection of the assay. (E) Single-step infection with chimeric
SINV-EEEV (MOI of 20, 6 h) and VSV-GFP (MOI of 3, 6.5 h). Infection was measured by flow cytometry. Infectivity is shown as the product of the percentage of
infected cells multiplied by the MFI of the positive cells. The data are normalized to values of WT and are shown as means  SD. Three experiments were each
performed in triplicate, and the results were assessed using one-way ANOVA with Dunnett’s posttest (*, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001;
n.s., not significant).
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treatment with the STING inhibitor partially reduced ISG expression at baseline in
Banf1 but not wild-type control cells (Fig. 4A). To corroborate these results, we edited
Banf1 expression in WT and STING KO (25) MEFs (Fig. S6B). In wild-type MEFs, loss of
Banf1 expression resulted in upregulation of several ISGs. In contrast, in STING KO cells,
editing of Banf1 had no impact on ISG expression (Fig. 4B). Given that the Banf1-
dependent ISG phenotype was mediated through STING, we next defined the pathway
by editing a more comprehensive set of DNA sensors (e.g., Aim2, cGAS, Ddx41, Ifi204,
Pqbp1, Pyhin1, and Zbp1) and signaling molecules (e.g., STING, Irf1, Irf3, and Irf8) in
FIG 3 ISGs are upregulated in ΔBanf1 cells independently of type I IFN signaling. (A) IFN1 gene expression in WT and ΔBanf1
BV2 cells. Three experiments were each performed in triplicate, and the results were assessed using an unpaired Student t test
on pooled data (n.s., not significant). (B) Inhibition of JAK signaling activity with 10 M ruxolitinib does not affect ISG (Rsad2,
left; Oas2, right) upregulation phenotype in Banf1 BV2 cells. (C) WT and Ifnar1/MEFs that were edited via CRISPR-Cas9 with
a control or Banf1 sgRNA and evaluated for ISG (Rsad2 and Ifit1) expression at baseline by qRT-PCR. (D) The Ifnar1 deficiency
was confirmed by flow cytometry. (E) Banf1 expression was reduced after gene editing as shown by immunoblotting. (F) The
Stat1 gene was edited in BV2 cells. WT cells and a clonal ΔStat1 BV2 cells (Fig. S5) were then edited with a control or Banf1
sgRNA and evaluated for ISG (Rsad2 and Oas2) expression by qRT-PCR. (B, C, and F) Data are means  SD. Three experiments
were each performed in triplicate, and the results were assessed using two-way ANOVA with Sidak’s posttest on pooled data
(*, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001).
Ma et al. ®












FIG 4 ISG upregulation in Banf1 cells occurs via a cGAS-STING-IRF3 pathway. (A) In Banf1 BV2 cells, the ISG induction phenotype is rescued partially
by treatment with NO2-FA (10 M for 15 min), an inhibitor of STING. Three experiments were each performed in triplicate, and the results were assessed
using two-way ANOVA (****, P  0.0001). (B) Banf1 was edited using CRISPR-Cas9 in STING/ and WT MEFs. Expression of Rsad2 and Oas2 mRNA is
shown. Three experiments were each performed in triplicate, and the results were assessed using two-way ANOVA (****, P  0.0001). (C) The indicated
DNA sensors and signaling molecules were edited using CRISPR-Cas9 in Banf1 BV2 cells. Two guide RNAs (sgRNA) were used for each gene. The
expression levels of Rsad2 (top) and Oas2 (bottom) mRNA are shown and were normalized to -actin. Three experiments were each performed in
triplicate, and the results were assessed using one-way ANOVA with Dunnett’s posttest (***, P  0.001; ****, P  0.0001). (D) Immunoblotting of cGAS,
STING, Irf1, Irf3, and -actin in gene-edited BV2 cells. The cell sample for Irf1 was treated with IFN- (50 ng/ml for 4 h) before harvesting and lysis. The
data are representative of two experiments.
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Banf1 BV2 cells. Among the target genes tested, only editing of cGAS, STING, and Irf3
resulted in loss of ISG expression in Banf1 BV2 cells (Fig. 4C and D and Fig. S7).
A deficiency in Banf1 results in accumulation of double-stranded DNA in the
cytosol. A recently published CRISPR/Cas9 screen showed that STAG2 regulated the
cGAS pathway by preventing a DNA damage response (26); accordingly, a loss of STAG2
expression resulted in increased levels of cytoplasmic DNA and induction of type I IFNs
and ISGs. Given the apparent similarities, we evaluated whether a deficiency of Banf1
resulted in activation of the DNA damage response by measuring phosphorylation of
the histone variant H2AX (H2AX). However, we did not observe higher levels of H2AX
in Banf1 deficient BV2 cells and MEFs relative to control (WT) or Banf1 complemented
cells, as judged by Western blotting (Fig. S8A and B) or immunofluorescence micros-
copy (Fig. S8C to E). Moreover, a loss of expression of Banf1 also was not associated
with formation of micronuclei in these cells (Fig. S8F). Thus, Banf1 and STAG2, despite
their similar effects on the cGAS-STING-IRF3 signaling pathway, likely act through
different mechanisms. We also inhibited the replication of endogenous retroviruses
with antiretroviral nucleoside inhibitors but observed no effect on basal ISG expression
in cells lacking Banf1 (Fig. S8G).
Because of the effects on cGAS activation, we next assessed by confocal microscopy
whether a loss of Banf1 expression resulted in basal accumulation of DNA in the cytosol.
Indeed, we observed substantially higher levels of double-stranded DNA puncta in the
cytosol of Banf1 BV2 cells than WT or Banf1-complemented cells (Fig. 5A and B). To
corroborate these findings, we performed cell fractionation and PCR experiments to
quantify the relative abundance of nuclear (18S) and mitochondrial (Cox1) gene DNA in
the cytosol of the different BV2 cells. The cytosolic levels of both the 18S nuclear and
Cox1 mitochondrial genes were higher in Banf1 BV2 cells than in WT and Banf1-
complemented cells (Fig. 5C and D). To assess the effect of a loss of Banf1 expression
on mitochondrial morphology, we performed additional staining. Although no sub-
stantive change in mitochondrial morphology was observed in Banf1 BV2 cells, a
deficiency of Banf1 was associated with decreases in mitochondrial membrane poten-
tial (Fig. 5E and F), which is an indicator of mitochondrial permeability (27).
DISCUSSION
Using a CRISPR-Cas9 genome-wide screen that was designed to identify negative
regulators of the IFN signaling pathway and ISG expression, we identified Banf1 as a
gene that inhibited cell surface expression of Bst2, a well-characterized ISG. However,
rather than modulate type I IFN signaling directly, editing of Banf1 resulted in greater
basal expression of multiple ISGs, and this effect occurred through a cGAS-STING-IRF3
pathway. Unexpectedly, our screen failed to identify any established negative regula-
tors (e.g., SOCS genes or others [5]) of the IFNAR signaling pathway. Although further
analysis is warranted, the dose or timing of exposure of IFN- used may have desen-
sitized an IFN signaling response, which could have precluded the identification of
negative regulators of the pathway.
When Banf1 expression was reduced, we observed global changes in transcription
of ISGs and alteration of the epigenetic state with histone acetylation of the ISG
promoters. Mechanistic studies revealed that Banf1 prevents accumulation of self,
double-stranded DNA in cytosol, which minimizes recognition by cGAS and activation
of the STING pathway. A loss of expression of Banf1 expression in BV2 cells or MEFs,
however, was not associated with diminished cell viability or rates of proliferation or
induction of canonical DNA damage responses. Instead, double-stranded DNA accu-
mulated in the cytoplasm of Banf1 cells from both nuclear and mitochondrial sources.
The higher levels of double-stranded DNA resulted in basal ISG expression, which
reduced infection of several RNA and DNA viruses. Reciprocally, ectopic expression of
Banf1 resulted in lower ISG levels at baseline and greater WNV-Kunjin and SINV-EEEV
infection. Together, these findings suggest that Banf1 expression levels under homeo-
static conditions may regulate amounts of double-stranded DNA in the cytoplasm and
help to set the basal ISG tone that primes antiviral defenses. Further studies are
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required to assess whether immune and nonimmune cells and quiescent and dividing
cells differentially express Banf1 and ISGs. It is plausible that some cells might regulate
basal expression of ISGs in a cGAS-dependent manner (28) by modulating expression
of Banf1. Notwithstanding our findings showing that Banf1 expression attenuates basal
expression of ISGs, in other contexts Banf1 can have direct antiviral effects. With
FIG 5 Higher levels of double-stranded DNA in the cytosol of Banf1-deficient cells. (A) Cytoplasmic DNA was evaluated in wild-type (WT), ΔBanf1, and Banf1
complemented (TC) ΔBanf1 BV2 cells using an anti-double-stranded DNA antibody. Confocal microscopy shows cytoplasmic DNA spots (anti-double-stranded
DNA, green) and nuclei (DAPI, blue). Scale bar, 10 m. Five experiments were conducted, with 15 to 20 fields viewed each. (B) Cytoplasmic DNA spots were
quantified with Velocity imaging software for 300 to 1,000 cells of each experiment. The number of double-stranded DNA spots per cell was compared using
a one-way ANOVA with Dunnett’s posttest (**, P 0.01; n.s., not significant). (C) The abundance of a nuclear 18S gene in the cytosol and nucleus was measured
with qPCR in WT, Banf1, and TC BV2 cells (three experiments; one-way ANOVA with Dunnett’s posttest; ***, P  0.001; n.s., not significant). (D) The
mitochondrial gene Cox1 also shows higher levels in cytosol of Banf1 BV2 cells than WT and TC cells (three experiments; one-way ANOVA with Dunnett’s
posttest; ****, P  0.0001; n.s., not significant). (E and F) A loss of Banf1 expression results in decreased potential of the mitochondrial membrane. (E)
Mitochondria were stained with MitoTracker Green (green, independent of mitochondria membrane potential) and tetramethylrhodamine methyl ester (TMRM,
red, requires intact mitochondrial potential). In Banf1 BV2 cells, less TMRM staining is seen. The images are representative of three experiments. (F) The level
of TMRM staining was quantified with flow cytometry. Three experiments were each performed, and the results were assessed using one-way ANOVA with
Dunnett’s posttest (***, P  0.001; n.s., not significant).
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retroviruses, Banf1 acts as a barrier to chromosomal integration (13) and, for poxviruses,
it acts to inhibit replication of exogenous viral DNA in the cytoplasm (29).
Our initial analysis suggested that Banf1 might act analogously to other recently
described genes that modulate cGAS activation, type I IFN production, and ISG expres-
sion, including Trex1 (30), ATM (31), LATS1/2 (32), and STAG2 (26), as well as the genes
causing Fanconi anemia (33) and Hutchinson-Gilford progeria syndrome (34). However,
these studies suggested that the DNA damage responses or activation of retroviral or
transposon elements from the chromosome are the source of DNA that activates the
intracellular sensing and innate immune signaling pathways. Unexpectedly, in the
Banf1-deficient cells we tested, we did not detect activation of the DNA damage
response as judged by an absence of expression of the marker H2AX or evidence of
staining in cytoplasm. In comparison, some individuals with progeroid syndrome
encode a homozygous mutation in Banf1 that impairs protein stability and is associated
with fibroblasts having nuclear lamina abnormalities (35). It remains possible that
nuclear chromatin fragments in the cytoplasm exist in Banf1-deficient cells; however,
these are too small to activate canonical pH2A.X signaling, but they are large enough
to be sensed by cGAS.
In separate studies, we inhibited the replication of endogenous retroviruses with
antiretroviral nucleoside inhibitors but observed no effect on basal ISG expression in
cells lacking Banf1. In both BV2 microglial cells and MEFs, the enhanced ISG expression
observed in the setting of reduced expression of Banf1 occurred independently of type
I IFN signaling or Stat1 expression. However, Banf1-modulated ISG expression was
dependent on IRF3, which can regulate a set of ISGs directly, independently of IFN
expression or signaling (23). Future studies in additional cell types are warranted to
define why a loss of Banf1 expression and activation of a cytosolic recognition occurs
through an IRF3-dependent yet IFN-independent pathway.
In cells from premature aging syndromes, damaged nuclear DNA leaks to the
cytosol, accumulates when the machinery to remove or degrade this DNA malfunc-
tions, and induces an inflammatory cytokine response via the STING pathway (36, 37).
Banf1 is a component of the nuclear lamina and can bind double-stranded DNA as a
highly ordered nucleoprotein complex in a sequence-independent manner (38). In-
deed, Banf1 acts as a bridge between chromosomal DNA and nuclear membrane
proteins and has a critical function in nuclear reassembly during mitosis (11, 39).
Consistent with these data, although we reduced Banf1 expression using multiple
sgRNA and gene editing in both BV2 cells and MEFs, we never obtained a complete
null, as determined by gene sequencing and immunoblotting. Banf1 protein also was
observed to accumulate at sites of nuclear envelope rupture in the context of cancer
cell migration and deformation through tight interstitial spaces (40). These studies link
Banf1 to control or protection against accumulation of double-stranded DNA in the
cytoplasm presumably from nuclear sources. Indeed, we observed accumulation of
nuclear DNA in the cytosol in cells deficient in the expression of Banf1, which could
accumulate over multiple rounds of cell division even without marked effects on cell
division or viability. Beyond its role in limiting accumulation of double-stranded DNA
from nuclear sources, our experiments suggest that Banf1 also may directly or indirectly
affect mitochondrial integrity or function. Our cell fractionation studies showed an
enrichment of mitochondrial DNA in the cytosol in Banf1-deficient cells, and this was
associated with altered mitochondrial potential but not morphology. Even moderate
mitochondrial stress in Banf1-deficient cells might lead to the release of damage-
associated molecular patterns that activate innate immunity via cGAS and STING. What
remains uncertain is the linkage between Banf1 and mitochondrial integrity, and
whether Banf1 has additional functions in regulating mitophagy, which limits activation
of cGAS and STING by minimizing levels of cytosolic mitochondrial DNA (41). Another
unresolved question is where cGAS localizes in Banf1-deficient cells to trigger double-
stranded DNA binding and ISG induction. Although we attempted to perform immu-
nofluorescence microscopy with commercial anti-mouse cGAS antibodies, these results
were difficult to interpret because of background staining in cGAS/ cells. In the
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field, consensus is lacking as to where cGAS recognizes self and foreign DNA. In
addition to its described localization in the cytosol (42), cGAS can be tethered to the
nucleus (43) or localized to the plasma membrane via the actions of an N-terminal
phosphoinositide-binding domain (44).
Overall, our studies add to an emerging literature that defines how different families
of proteins regulate accumulation of host DNA in the cytoplasm. This regulatory
network is critical for cellular homeostasis to enable a rapid innate immune response
to pathogens but also limit adventitious inflammation under settings (e.g., cell division,
stress, and deformation) when self DNA may accumulate in the cytosol.
MATERIALS AND METHODS
Cells, viruses and reagents. BV2 microglial cells (a gift from Stephanie Karst, University of Florida),
C57BL/6 MEFs, and BHK-21, Vero, and HEK 293T cells (ATCC) were cultured in Dulbecco modified Eagle
medium (DMEM) with 10% fetal bovine serum (FBS), 1% HEPES, and 1% penicillin-streptomycin unless
otherwise indicated. For BV2 cells and MEFs, 2.5 g/ml of puromycin (InvivoGen), 4 g/ml blasticidin
(InvivoGen), and 200 g/ml hygromycin (InvivoGen) were added for plasmid selection depending on the
application.
The following viruses were used: chimeric SINV-EEEV-GFP (45), VSV-GFP (Indiana) (46), HSV-1 (strain
17) (47), and WNV-Kunjin (48). Because EEEV is a BSL-3 select agent pathogen, we used the chimeric
SINV-EEEV BSL-2 pathogen that incorporates the nonstructural genes and RNA replication control
elements of a Sindbis virus (SINV; strain TR339) with the structural genes (C-E3-E2-6K-E1) of an EEEV
isolate (strain FL93-939); the green fluorescent protein (GFP) reporter gene was added to an additional
subgenomic promoter. SINV-EEEV-GFP was propagated in BHK-21 cells, and titers were determined by a
focus forming assay (FFA). WNV-Kunjin was propagated in Vero cells and titrated by FFA, and VSV-GFP
and HSV-1 were propagated in Vero cells and titrated by plaque assays. The Jak1/2 inhibitor ruxolitinib
(INCB018424) was purchased from Selleckchem (catalog no. S1378). Cells were treated at 10 M
ruxolitinib or vehicle for 12 h. The STING signaling inhibitor NO2-FA was obtained (Cayman Chemicals),
together with control lipids. Cells were treated with 10 M NO2-FA for 15 min and washed with fresh
media, and samples were harvested 10 h later to minimize possible cytotoxic effects. The nucleoside
reverse transcriptase inhibitor (lamivudine [3TC]) used in this study was USP grade and obtained
commercially (Aurobindo Pharma). Cells were treated with 10 M 3TC for 2 weeks and harvested for
quantitative reverse transcription-PCR (qRT-PCR).
Cell viability and cytotoxicity assays were conducted using the luminescent cell viability assay
(CellTiter-Glo; Promega) according to the manufacturer’s instructions. Luminescence was analyzed on a
reader (BioTek Synergy H1) at room temperature with a 0.5-s integration time per well. Cell counting was
conducted by flow cytometry (MACSQuant 10; Miltenyi Biotec).
Gene editing with CRISPR/Cas9. Oligonucleotides for sgRNA (for the sequences, see Table S2A)
were synthesized commercially (Integrated DNA Technology), cloned into the plasmid lentiCRISPR v.2
(Addgene 52961), and packaged by cotransfection with two helper plasmids (psPAX2 [Addgene, catalog
no. 12260] and pMD2.G [Addgene, catalog no. 12259]) into HEK-293T cells with Lipofectamine 3000
(Invitrogen) according to the manufacturer’s instructions. The sgRNAs selected were the top two
optimized guides from a designed library for maximum gene-editing activity and minimum off-target
effects (49). Cells were transduced with lentiviruses expressing individual sgRNA and selected with
puromycin for 7 days. An irrelevant sgRNA (GAAGTTCGAGGGCGACACCC) with no target in the mouse
genome also was transduced as a negative control. For some experiments, cells were isolated by
limiting-dilution single-cell cloning. Gene editing at the target site was evaluated by next generation
sequencing on an Illunima HiSeq 2500 platform (Genome Technology Access Center, Washington
University) and/or Western blotting.
Flow cytometry. For staining of cell surface antigen, cells were detached with Cellstripper (Corning)
and resuspended in PBS with 0.5% FBS and 1 mM EDTA (FACS [fluorescence-activated cell sorting]
buffer). Bst2 was stained with phycoerythrin (PE)-labeled anti-Bst2 (BioLegend, clone 129C1; 1:500 in
FACS buffer) and anti-mouse CD16/CD32 (eBioscience; 1:250 in FACS buffer) on ice for 45 min. Ifnar1 was
stained with 1 g/ml of anti-mouse Ifnar1 (clone MAR1-5A3; BioXcell) at room temperature for 45 min,
followed by incubation with a goat anti-mouse IgG (HL) Alexa Fluor 647 (Thermo Fisher, catalog no.
A21236; 1:1,000 in FACS buffer) at room temperature for 30 min. For cells infected with GFP-labeled
viruses (SINV-EEEV-GFP and VSV-GFP), cells were detached with trypsin and fixed with 1% paraformal-
dehyde (PFA) at room temperature for 15 min. Flow cytometry was performed on a MACSQuant Analyzer
10 (Miltenyi Biotec), and data were analyzed using FlowJo 10.6.1.
CRISPR-Cas9 genome-wide screen. The mouse Asiago sgRNA CRISPR library in BV2 cells has been
published (18) and was a gift (Herbert Virgin, Washington University). The library contains four inde-
pendent sublibraries, each containing a unique sgRNA targeting each of 20,077 mouse genes (18, 49). We
used two of the sublibraries (1 and 5) for the screen. For each sublibrary, 2 107 cells containing sgRNAs
were seeded into two T-175 tissue culture flasks and cultured for 16 h. Cells were treated with 40 IU/ml
mouse IFN- (PBL Assay Science) for 16 h and detached with Cellstripper (Corning). Cells were incubated
with PE-labeled anti-Bst2 (BioLegend, clone 129C1) and anti-mouse CD16/CD32 (eBioscience) on ice for
45 min. The cells were sorted for the population with highest (top 1%) surface expression of Bst2 using
a MoFlo high-speed cell sorter (Beckman Coulter, Siteman Flow Cytometry Core, Washington University)
and expanded in DMEM supplemented with 10% FBS. When enough cells accumulated (2 107), a
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second round of sorting was conducted. Subsequently, genomic DNA was extracted from the control
cells (2 107) and sorted cells (1 107), respectively. The sgRNA enriched was amplified and subjected
to next generation sequencing using an Illumina HiSeq 2500 platform (Genome Technology Access
Center, Washington University). The sgRNA sequences against specific genes were determined after
removal of the tag sequences using the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) and
cutadapt 1.8.1. sgRNA sequences were analyzed using a published computational tool (MAGeCK) (19)
(see Table S1).
Hit validation. Genes with the highest rankings in both library screens were validated using two
independent sgRNAs (Fig. S2). The sgRNAs were cloned into the plasmid lentiCRISPR v.2; lentiviruses
were generated and BV2 cells were transduced as described above. An irrelevant sgRNA (GAAGTTCGA
GGGCGACACCC) with no target in the mouse genome also was transduced as a control.
For complementation of Banf1 expression, the full-length mouse Banf1 open reading frame corre-
sponding to the transcript (NM_001038231.2) was synthesized (Integrated DNA Technologies) and
cloned into the lentivirus vector pLV-EF1-IRES-BLAST (Addgene 85133) between BamHI and MluI
restriction enzyme sties. The Banf1 sgRNA target sequence and the PAM sequence were mutated
synonymously (TGACGTCCTGAGCAAGAGGC to TGACGTCCTGAGTAAAAGAC; TGG to TCG) to avoid recut-
ting of the reintroduced gene. Lentiviruses were generated as described above. Cells transduced with
lentiviruses were selected with 4 g/ml blasticidin (InvivoGen) for 7 days. An empty vector was trans-
duced as a negative control. The ectopic expression of Banf1 was confirmed with Western blotting.
Viral infections. BV2 cells were inoculated with SINV-EEEV-GFP (multiplicity of infection [MOI] of 20)
for 6 h or VSV-GFP (MOI of 3) for 6.5 h. Low-MOI infections also were conducted using an MOI of 0.001
for 30 h for SINV-EEEV-GFP and an MOI of 0.001 for 18 h for VSV-GFP. Cells were harvested using trypsin
digestion and fixed in 1% PFA for 15 min at room temperature. Cells then were subjected to flow
cytometric analysis (MACSQuant Analyzer 10; Miltenyi Biotec) using FlowJo software (Tree Star). Virus
infection was defined as a product of the percentage of GFP-positive cells multiplied by the mean
fluorescence intensity (MFI) of the positive cells. Growth curves of HSV-1 and WNV-Kunjin was conducted
by inoculating BV2 cells at MOIs of 0.05 and 0.01, respectively. Supernatants were collected at specified
time points, and titers were determined with a plaque-forming assay (HSV-1) or an FFA (WNV-Kunjin).
Western blotting. Cell lysates were prepared using radioimmunoprecipitation assay (RIPA) buffer
(Thermo Fisher) supplemented with a cocktail of protease and phosphatase inhibitors (Thermo Fisher) on
ice. Protein concentration was determined with a BCA protein assay (Pierce, catalog no. 23227). Gel
electrophoresis was performed on 4 to 12% Bis-Tris NuPAGE gel (Invitrogen) and transferred onto
polyvinylidene difluoride membranes according to the manufacturer’s instructions (iBLOT2; Life Tech-
nologies). Membranes were blotted with the following primary antibodies: Banf1 (BAF antibody A-11
[Santa Cruz, sc-166324]; 1:500), Irf3 (CST 4302; 1:1,000), cGAS (CST 31659; 1:1,000), Irf1 (CST 8478; 1:1,000),
Aim2 (CST 63660; 1:1,000), Ddx41 (CST 15076; 1:1,000), Pqbp1 (Proteintech 16264-1-AP; 1:500), H2AX
(phospho S139) (Abcam, ab26350 [1:5,000] or CST 9718 [1:1,000]), H2AX (CST 2595; 1:1,000), actin (CST
3700; 1:3,000) and STING (CST 13647; 1:1,000). Horseradish peroxidase-conjugated goat anti-rabbit
(Pierce, 31460; 1:5,000) or anti-mouse (Sigma, A8924; 1:5,000) IgG was used as a secondary antibody.
Protein bands were visualized with chemiluminescence substrate (Thermo Fisher, 34577) and autora-
diograph film (MIDSCI).
Gene expression analysis by RT-qPCR. For RT-qPCR, total RNA was extracted from 2 to 5 104 cells
using an RNeasy 96 kit (Qiagen) and eluted in 100 l of water. Real time PCR was performed on a
Quantstudio 6 real-time PCR machine (Applied Biosystyem) in a 20-l reaction consisting of 9 l of total
RNA, 10 l of 2 master mix (TaqMan RNA-to-Ct 1-step kit; Applied Biosystems), 900 nM concentrations
of each primer, and a 250 nM concentration of the probe. The primers and probes were synthesized by
IDT, and the sequences are listed in Table S2B. Mouse -actin (NM_007393) was used as a comparison
reference (IDT assay ID Mm.PT.39a.22214843.g).
RNA-Seq, ultra-low-input ChIP-Seq, and data processing. For RNA-Seq, total RNA from 106 control
BV2 cells, Banf1 gene-edited cells, and Banf1-complemented cells were extracted using RNeasy minikit
(Qiagen). The quality of the RNA samples was evaluated using Bioanalyzer 2100 (Agilent). Libraries were
sequenced on Illumina HiSeq2500 platforms (Genome Technology Access Center, Washington Univer-
sity). The reads were aligned to the mm9 build using Bowtie2 to map clean reads to reference genes.
RPKM values were determined using STAR aligner.
Ultralow Input ChIP-Seq was performed as described previously (50). Briefly, aliquots of 105 cells were
suspended in 20 l of EZ nuclei isolation buffer (Sigma) and digested using 20 l of MNase (NEB MNase
buffer, 1 l of MNase, and 3 mM dithiothreitol) for 5 min at 37°C, which was quenched by adding 4.4 l
of 100 mM EDTA and 4.4 l of 1% Triton X-100 and 1% deoxycholate. Digested nucleosomes were diluted
in complete ChIP buffer (20 mM Tris-HCl [pH 8.0], 2 mM EDTA, 150 mM NaCl, 0.1% Triton X-100, 5 mM
sodium butyrate, and protease inhibitors [Roche]), precleared using Dynabeads (Invitrogen) for 1 h at 4°C,
and subjected to immunoprecipitation overnight at 4°C (0.1 g of H3K27ac; Abcam, ab4729). Bead
chromatin complexes were washed sequentially using low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris [pH 8.0], 150 mM NaCl) and high-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris [pH 8.0,] 500 mM NaCl) and then eluted with 1% SDS and 100 mM NaHCO3 for 1 h at 65°C.
DNA was purified using Maxtract tubes (Qiagen) and precipitated overnight. For ATAC-Seq, aliquots of
5 104 cells were processed according to the manufacturer’s instructions (Nextera DNA library prepa-
ration kit; Illumina).
Deep sequencing was performed on an Illumina HiSeq2500 1 50 (Genome Technology Access
Center, Washington University). After demultiplexing, files were processed for alignment, peak calling,
RPKM normalization, and visualization using NovaAlign, Macs2, DeepTool’s BamCoverage (51), and the
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UCSC Genome Browser (52), respectively. The R packages ChIPpeakAnno (53) and ggplot2 were used to
assign H3K27 acetylation peaks to closest genes and plotting. Raw and processed data are available on
the GEO database (GSE141386).
Immunofluorescence microscopy. For H2AX staining, MEFs were seeded onto microscope cover-
slips and fixed for 25 min with 3.2% PFA in 1 phosphate-buffered saline (PBS). The cells then were
washed extensively with IF wash buffer (1 PBS, 0.5% NP-40, 0.02% NaN3) and blocked with IF blocking
buffer (IF wash buffer plus 10% FBS) for at least 30 min. Cells were incubated with mouse anti-pH2A.X
antibody (Abcam, 26350; 1:1,000 in IF blocking buffer) for 1 h at 4°C. Cells were washed three times with
IF washing buffer and then stained with secondary antibody (1:1,000; goat anti-mouse conjugated with
Alexa Fluor 594; Invitrogen, catalog no. A11032) and Hoechst (1:5,000; BD Biosciences 33342) diluted in
IF blocking buffer for 1 h at 4°C. Coverslips were rinsed extensively and then mounted using Prolong
Gold mounting medium (Invitrogen, catalog no. P36930). Epifluorescence microscopy was performed on
an Olympus fluorescence microscope (BX-53) using an UPlanS-Apo 60/1.35 oil immersion lens with
immersion oil from Millipore (104699). Images were obtained at room temperature using an ORCA-
Flash4.0 LT digital camera (Hamamatsu, catalog no. C11440) and cellSens Dimension software. All images
on the same channel were acquired using the same exposure time, and no digital gain was applied
during image capture. Raw images were exported into Adobe Photoshop, and for any adjustments in
image contrast or brightness, the levels function was applied. For focus quantitation, at least 100 cells
were analyzed in triplicate.
For cytoplasmic double-stranded DNA staining, 8,000 BV2 cells in 250 l of DMEM media were
seeded into wells of a chamber slide (Nunc, Lab-Tek II) and cultured for 2 days. Cells were stained with
MitoTracker Deep Red FM (Thermo Fisher, catalog no. M22426; 1 M) in Opti-MEM at 37°C for 30 min,
and then fixed with 4% PFA in PBS for 20 min at room temperature. Cells were washed with PBS and
blocked with IFA buffer (0.1% saponin and 5% goat serum in PBS) for 10 min at room temperature. Cells
then were stained with primary antibody (Santa Cruz, double-stranded DNA marker antibody [HYB331-
01], sc-58749, diluted 1:100 in IFA buffer) at 4°C for 24 h. After washing with PBS and blocking with IFA
buffer at room temperature for 10 min, the cells were incubated with a secondary antibody (Thermo
Fisher, goat anti-mouse Alexa Fluor 488, catalog no. A11029; 1:250 in IFA) at room temperature for 1 h.
After washing and staining with DAPI (4=,6=-diamidino-2-phenylindole; 1:500 in IFA buffer), cells were
mounted with Prolong Gold mounting medium (Invitrogen, catalog no. P36930). Confocal microscopy
was performed on a Zeiss LSM 880 confocal microscope using a Plan-Apochromat 63/1.4 oil immersion
lens (Zeiss). Images in each experiment were acquired at identical settings (detector gain of 590 and 600
for DAPI and Alexa Fluor 488, respectively; zoom, 1.5 for each). Images were analyzed with Volocity
software (Quorum Technologies).
Confocal microscopy imaging of mitochondria in live cells. For live cell imaging, cells were grown
in four-chamber glass-bottom dishes (D35C4-20-1.5-N; Cellvis). Cells were loaded with MitoTracker Green
FM (200 nM; Thermo Fisher) together with Image-iT TMRM reagent (1:1,000; Thermo Fisher) in Live Cell
Imaging Solution (Thermo Fisher, catalog no. A14291DJ) at 37°C for 30 min. Cells then were washed three
times and imaged in live cell imaging solution at 37°C and 5% CO2. The cells were analyzed using Zeiss
LSM 880 Airyscan confocal microscope (objective Plan-Apochromat 63/1.4 oil; Zeiss) equipped with a
Pecon stage-top incubator with controlled temperature and CO2. Images in each experiment were
acquired at identical settings (Ex/Em 561/606, detection wavelength of 571 to 641, detector gain
646.2 for TMRM; Ex/Em 488/530, detection wavelength of 499 to 561, detector gain 837.0 for
MitoTracker Green FM).
Analysis of mitochondrial membrane potential by flow cytometry. Cells were loaded with
Image-iT TMRM reagent (1:1,000; catalog no. I34361; Thermo Fisher) in complete culture medium at 37°C
for 30 min. The cells were then washed three times with PBS and resuspended in PBS. Analysis of the
stained cells was carried out using Canto II flow cytometer (Becton Dickinson), and data were analyzed
with FlowJo v10.6.1 software (Tree Star).
Quantification of cytosolic DNA. The method to isolate cytosolic DNA is modified from a published
paper (54). Briefly, 106 BV2 cells were placed in individual wells of a six-well plate and cultured at 37°C
for 16 h. The cells were washed once with PBS and lysed by adding 100 l of 1% NP-40. Lysates were
scraped and gathered in a 1.5-ml tube and incubated on ice for 15 min. Lysates were centrifuged at
16,000 g for 15 min at 4°C, and the supernatant and cell pellets were separated. The supernatant was
subjected to DNA extraction with the DNeasy blood and tissue kit (Qiagen). The pellet was lysed with
180 l of ALT buffer (DNeasy blood and tissue kit; Qiagen) and 20 l of proteinase K, followed by
incubation at 56°C for 10 min. DNA was extracted according to the manufacturer’s instructions. For both
supernatants and pellets, DNA was eluted with 100 l of AE (Tris-HCl-EDTA) elution buffer. The DNA was
diluted 50 to load 7 l per qPCR (SYBR green; KAPA HiFi HotStart). The abundance of a nuclear 18S
gene (forward primer, 5=-TAGAGGGACAAGTGGCGTTC-3=; reverse primer, 5=-CGCTGAGCCAGTCAGTGT-3=)
and a mitochondrial gene, Cox1 (mt-Cox1_F, TCGGAGCCCCAGATATAGCATT; mt-Cox1_R, CTGCTCCTGCT
TCTACTATTGATG), was measured. The cytoplasmic DNA level was expressed as a ratio to those in the
pellet.
Statistical analysis. Data from at least three independent experiments were pooled and subjected
to a normality test prior to significance test. Nonnormal distribution data were log transformed.
Significance was tested by one-way analysis of variance (ANOVA), with Dunnett’s posttest; two-way
ANOVA, with Tukey’s posttest; or unpaired two-tailed t test. Data were analyzed using Prism version 8
(GraphPad). Statistical significance was assigned when P values were0.05.
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